Editorial: PNPLA3 genotype and liver diseases-more than non-alcoholic fatty liver disease
- PMID: 32592253
- DOI: 10.1111/apt.15788
Editorial: PNPLA3 genotype and liver diseases-more than non-alcoholic fatty liver disease
Comment in
-
Editorial: PNPLA3 genotype and liver diseases-more than non-alcoholic fatty liver disease. Authors' reply.Aliment Pharmacol Ther. 2020 Jul;52(2):391-392. doi: 10.1111/apt.15873. Aliment Pharmacol Ther. 2020. PMID: 32592246 No abstract available.
Comment on
-
The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis.Aliment Pharmacol Ther. 2020 Jun;51(11):1160-1168. doi: 10.1111/apt.15722. Epub 2020 Apr 22. Aliment Pharmacol Ther. 2020. PMID: 32323349
References
REFERENCES
-
- Yu M-L, Huang C-F, Huang J-F, et al. Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients. Hepatology. 2011;53:7-13.
-
- Shen J, Wong GL, Chan HL, et al. PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome. Aliment Pharmacol Ther. 2014;39:532-539.
-
- Wang C-W, Lin H-Y, Shin S-J, et al. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population. Liver Int. 2011;31:1326-1331.
-
- Trepo E, Valenti L. Update on NAFLD genetics: from new variants to the clinic. J Hepatol. 2020. https://doi.org/10.1016/j.jhep.2020.02.020. (In press).
-
- Mederacke Y, Kirstein MM, Großhennig A, et al. The PNPLA3 rs738409 GG genotype is associated with mortality in 239 patients with autoimmune hepatitis. Aliment Pharmacol Ther. 2020;51:1160-1168.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical